|
Ideaya Biosciences Inc (NASDAQ: IDYA) |
|
Ideaya Biosciences Inc
IDYA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Ideaya Biosciences Inc growth rates, revenue grew
by 78.43 % in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 814
Major Pharmaceutical Preparations industry recorded
growth of revenues by 11.85 %
Ideaya Biosciences Inc net loss increased from $-34 millions, to $-130 millions in IV. Quarter 2024,
• More on IDYA's Growth
|
|
Ideaya Biosciences Inc realized a net loss in trailing twelve months.
Ideaya Biosciences Inc realized cash reduction of $ -0.89 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 237.07.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.37.
• More on IDYA's Valuation
|
|
|
|
|
Ideaya Biosciences Inc realized net loss in trailing twelve months.
Ideaya Biosciences Inc realized cash outflow of $ -0.89per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 237.07.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.37.
Ideaya Biosciences Inc Price to Book Ratio is at 1.57 lower than Industry Avg. of 81.26. and higher than S&P 500 Avg. of 0.01
• More on IDYA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com